Scanbo今天发射新的实时葡萄糖监测器,计划将来进行非侵入性试验。 Scanbo launches new real-time glucose monitor today, with future non-invasive tests planned.

Scanbo是一家医疗技术公司,已宣布计划扩大其葡萄糖监测系统,首先从今天可用的新装置开始,实时跟踪葡萄糖含量。 Scanbo, a medical technology company, has announced plans to expand its glucose monitoring system, starting with a new device available today that tracks glucose levels in real time. 该公司的路线图包括今后发布更多的诊断工具,重点是减少对侵入性血液检测的需要。 The company's roadmap includes future releases of additional diagnostic tools, with a focus on reducing the need for invasive blood tests. 下一个阶段是D19预期的,将采用更先进的非侵入性测试能力,目的是改善病人的便利和长期健康管理。 The next phase, expected by D19, will introduce more advanced non-invasive testing capabilities, aiming to improve patient convenience and long-term health management. 该公司强调,在其开发时间表中,准确性和监管批准的重要性。 The company emphasized the importance of accuracy and regulatory approval in its development timeline.